Rudolph E. Tanzi
Genetics · 2000–2019
A researcher in the Science corpus: 25 papers; trusts 10 researchers and is trusted by 16 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 124 citations into it
- Molecular Biology — 113 citations into it; #4,693 of 17,773 by trust here, #2,783 by citations
- Physiology — 99 citations into it; #240 of 2,276 by trust here, #85 by citations
- Neurology — 53 citations into it; #964 of 1,455 by trust here, #258 by citations
- Pharmacology — 19 citations into it; #665 of 1,112 by trust here, #415 by citations
- Statistics and Probability — 18 citations into it
- Immunology — 17 citations into it
- Computational Theory and Mathematics — 11 citations into it
Whom Rudolph E. Tanzi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Rudolph E. Tanzi overall
Papers from Rudolph E. Tanzi's perspective
Ordered by how strongly the researchers Rudolph E. Tanzi trusts endorse each paper. Same corpus, a different order for every researcher.
- Siglecs and their roles in the immune system (Nature reviews. Immunology)
- Finding the missing heritability of complex diseases (Nature)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics)
- Principal components analysis corrects for stratification in genome-wide association studies
- Why Most Published Research Findings Are False
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics (Science)
- Rare Variants Create Synthetic Genome-Wide Associations (PLoS Biology)
- Genome-wide association studies for complex traits: consensus, uncertainty and challenges (Nature reviews genetics)
- Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
- Tau-mediated neurodegeneration in Alzheimer's disease and related disorders (Nature Reviews Neuroscience)
Their papers
- The genetics of Alzheimer disease. (2012) — 1,230 citations
- The genetic epidemiology of neurodegenerative disease. (2005) — 632 citations
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database (2007) — 1,885 citations
- Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses (2008) — 788 citations
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
- Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. (2008) — 658 citations
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta (2013) — 917 citations
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide (2010) — 928 citations
- Induced Adult Neurogenesis plus BDNF Mimicks the Effects of Exercise on Cognition in an Alzheimer’s Mouse Model (2018) — 722 citations
- Amyloid-β Peptide Protects Against Microbial Infection In Mouse and Worm Models of Alzheimer’s Disease (2016) — 859 citations
- A three-dimensional human neural cell culture model of Alzheimer’s disease (2014) — 1,090 citations
- Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model (2012) — 962 citations
- An iron-export ferroxidase activity of β-amyloid protein precursor is inhibited by zinc in Alzheimer’s Disease (2010) — 660 citations
- The genetics of Alzheimer disease: back to the future. (2010) — 866 citations
- Association between microdeletion and microduplication at 16p11.2 and autism. (2008) — 1,609 citations
- Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database (2008) — 1,082 citations
- Mapping autism risk loci using genetic linkage and chromosomal rearrangements (2007) — 1,398 citations
- Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD (2005) — 886 citations
- Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo (2003) — 1,348 citations